Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

0.9507
+0.01081.15%
Post-market: 0.9489-0.0018-0.19%16:35 EDT
Volume:188.82K
Turnover:180.67K
Market Cap:6.27M
PE:-0.23
High:1.01
Open:0.9700
Low:0.9006
Close:0.9399
Loading ...

Alzamend Neuro Inc: Plans to Initiate Phase Ii Clinical Study of Al001 for Treatment of Patients With Mdd in Q4 of 2025

THOMSON REUTERS
·
18 Mar

Alzamend Neuro announces initiation of Phase II trial of AL001

TIPRANKS
·
11 Mar

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

GlobeNewswire
·
11 Mar

BRIEF-Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General Hospital

Reuters
·
04 Mar

Alzamend Neuro announces initiation date of Phase II trial of AL001

TIPRANKS
·
04 Mar

Alzamend Neuro Announces Initiation Date of Phase Ii Clinical Trial of Al001 for Treatment of Bipolar Disorder to Take Place at Massachusetts General Hospital

THOMSON REUTERS
·
04 Mar

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

GlobeNewswire
·
04 Mar

Ambarella Appoints Chantelle Breithaupt as Independent Director

TIPRANKS
·
01 Mar

Alzamend Neuro (ALZN) Gets a Hold from Maxim Group

TIPRANKS
·
27 Feb

Alzamend Neuro Announces Initiation Date of First Phase Ii Clinical Trial of Al001 to Take Place at Massachusetts General Hospital

THOMSON REUTERS
·
25 Feb

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

GlobeNewswire
·
25 Feb

EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025

Benzinga
·
25 Feb

BRIEF-Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital

Reuters
·
19 Feb

Alzamend Neuro announces completion of head coil by Tesla Dynamic Coils

TIPRANKS
·
19 Feb

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase Ii Clinical Trials at Massachusetts General Hospital

THOMSON REUTERS
·
19 Feb

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Business Wire
·
19 Feb